NCT02613169View on ClinicalTrials.gov

Infant TB Infection Prevention Study

PHASE2CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

October 31, 2019

Study Completion Date

December 31, 2020

Conditions

Tuberculosis

Interventions

DRUG

Isoniazid

HIV-exposed uninfected infants will be randomized to receive either INH or no INH daily for 12 months for the prevention of Mycobacterium tuberculosis (MTB) infection.

Trial Locations (1)

Unknown

Kisumu County Hospital, Kisumu

All Listed Sponsors

collaborator

Thrasher Research Fund

OTHER

lead

University of Washington

OTHER

NCT02613169 - Infant TB Infection Prevention Study | Biotech Hunter | Biotech Hunter